The Department of the Army Medical Command awarded a blanket purchase agreement to Illumina, Inc. to provide sequencing consumables, equipment, and maintenance services in support of various research and medical programs. Under multiple firm fixed price call orders valued collectively at over $2 million, Illumina will deliver reagents, kits, and support plans for NextSeq and MiSeq sequencing systems located in Maryland, California, and elsewhere. The orders facilitate ongoing genomic research by...
The Department of the Navy Bureau of Medicine and Surgery awarded an Indefinite Delivery Contract (IDC) worth up to $3,332,295.75 to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. Under this single-award IDC, Illumina will provide nucleic acid sequencing reagents and positive controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing instruments used by the Naval Medical Research Center's Biological Defense Research Directorate (NMRC-BDRD) to characterize...
The Defense Health Agency (DHA) has awarded a single-award Blanket Purchase Agreement (BPA) valued at $7,433,000 to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The BPA, awarded in November 2023 with no set-asides, allows DHA to efficiently acquire standardized laboratory supplies, including MiSeq Reagent Kits, ForenSeq Kintelligence Reagents, and other reagents and consumables, to support the agency's ongoing genomic sequencing initiatives. The...
The federal contract IDV awarded to Meso Scale Diagnostics LLC, a for-profit limited liability company doing business as Meso Scale Discovery, is a single-award Indefinite Delivery Contract (IDC) with the Defense Health Agency (DHA), a defense agency, for the provision of reagents, consumables, assays, and equipment. This $2.28 million IDC has an ultimate completion date of August 16, 2029. Meso Scale Diagnostics, a Native American-owned small business, has extensive experience supporting...
The Defense Health Agency (DHA) awarded a $5.3 million single-award Blanket Purchase Agreement (BPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer of specialized genomic and proteomic research tools. The BPA, which runs through September 2027, enables DHA to issue firm-fixed-price delivery orders for Biodiscovery's proprietary MYBAITS DNA reagents, custom DNA extraction products, sequencing kits, and other genomic research materials....
The Defense Health Agency awarded a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $1,096,465.75 to Branch Medical LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract covers the delivery of a multiplex analyzer and associated reagents to support the agency's clinical testing and medical research requirements. Under this IDC, Branch Medical LLC has received several firm-fixed price delivery orders totaling over $630,000...
This indefinite delivery contract was awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $49,000,000 and a period of performance through December 21, 2026. The contract aims to procure laboratory supplies, including reagents, diagnostics, chemicals, biologicals, apparatus, equipment, and instruments, for use by the Department of Defense, Department of...
The Defense Health Agency awarded Promega Corporation an indefinite delivery vehicle in the form of a blanket purchase agreement valued at up to $11.5 million. The BPA enables the agency to place fixed price calls for DNA analysis equipment, reagents, and related products to support its biomedical research and healthcare programs. Between September 2020 and the present date, the agency has exercised this BPA to award Promega eight calls valued between $816 and $261,323.68 each. The calls require...
Diatec-S.R.L. was awarded a single award indefinite delivery contract by the Defense Health Agency to provide reagents for Vitros 5600 or XT7600 diagnostic systems. The contract has a potential value of $223,390.14 and a period of performance through May 16, 2025. No set-aside provisions were applied. Three firm fixed price delivery orders were subsequently awarded against the contract to supply reagents to DHA medical facilities in Italy. The first order, valued at $23,689.59, had a period of...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $1,297,062 and a performance period through August 13, 2029. Under this IDC, the VA has issued a $249,435 Firm Fixed Price delivery order to Illumina for TSO 500 library preparation and sequencing reagents. Illumina has previously provided a range of sequencing systems,...